CONDA starts this year of e-mail communication changing its newsletter design. This new layout is more clear and simple and would be easier to find the information . As always, Pronadisa™ e-news will continue to bring news concerning our business and fields of action. All of us here at CONDA hope that you will enjoy the new makeover and we welcome your feedback if you have any comments on it.

Arabhealth 2008 success
As every year, Laboratorios CONDA, was present at ARAB HEALTH 08 in Dubai. The fair drew more than 32,000 visitors including end user medical staff, hospital management and specialist dealers & distributors. It was a pleasure to meet up with over 120 companies from 30 different countries. This ensures us that we’re heading in the right direction and strengthening our position in the international market.

Having seen the success achieved, we would like to extend our gratitude to all of those present at our stand and we hope to see you within one year at ARAB HEALTH 2009.

-Top-

New products: agars
CONDA adds 3 new high performance and quality agars to its already wide range. These new products will be useful to those clients interested in raw materials as well as gelling agents to prepare culture media.

• BACTERIOLOGICAL AGAR HS (Cat. 1809)
• V AGAR (Cat. 1815)
• BACTERIOLOGICAL FLAKE AGAR (Cat. 1805)

Click on each product for detailed technical data sheets.

For more information, prices, samples and presentations, please contact your Export Area Manager or email us at mktg@condalab.com

-Top-

European Pharmacopoeia 6th Edition
The European Pharmacopoeia presents 2 sets of tests:

• The 1st test (Methods of the European Pharmacopoeia) gives reference for determining compliance with monographs.
• The 2nd set (Harmonized methods) also constitutes official methods of the European Pharmacopoeia.

The 2nd set presents tests developed in co-operation with the Japanese Pharmacopoeia and the United States Pharmacopoeia to achieve harmonised methods. It is intended to replace the 1st set by the 2nd set once the monographs concerned have been revised.

We are pleased to announce that the media manufactured at Conda comply with the changes issued in the 6th Edition of the European Pharmacopoeia.

The media list provided shows all the quality controls and technical data sheets that have been modified with accordance to the 6th Edition of the European Pharmacopoeia.

-Top-

We welcome information on your direct point of contact to facilitate communication with our marketing department. We are also interested in the events you are attending or participating in to promote CONDA products so we can help you on a marketing level. CONDA welcomes your ideas and suggestions. Please feel free to contact us at mktg@condalab.com.